Welcome to LookChem.com Sign In|Join Free

CAS

  • or

300665-25-2

Post Buying Request

300665-25-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

300665-25-2 Usage

Description

[2-(morpholin-4-yl)-5-nitrophenyl]methanol is a chemical compound characterized by its molecular formula C11H13N3O4. It is a yellow crystalline substance that is widely utilized in the synthesis of other organic compounds. [2-(morpholin-4-yl)-5-nitrophenyl]methanol is recognized for its potential applications in pharmaceutical research and drug development, attributed to its unique structural features and properties. The presence of a morpholine ring, a nitro group, and a phenyl group in its structure renders it a versatile building block for the creation of new molecules with potential therapeutic uses. Furthermore, the hydroxyl group in the molecule allows for additional modification and functionalization, making it a valuable asset in organic chemistry research and drug discovery.

Uses

Used in Pharmaceutical Research and Drug Development:
[2-(morpholin-4-yl)-5-nitrophenyl]methanol is used as a building block for the synthesis of new molecules with potential therapeutic uses. Its unique structure, which includes a morpholine ring, a nitro group, and a phenyl group, contributes to its versatility in creating molecules with diverse applications in the pharmaceutical industry.
Used in Organic Chemistry Research:
[2-(morpholin-4-yl)-5-nitrophenyl]methanol is used as a valuable tool in organic chemistry research due to its ability to undergo further modification and functionalization through its hydroxyl group. This characteristic makes it an essential component in the development of novel chemical compounds and the advancement of organic chemistry.
Used in Chemical Synthesis:
[2-(morpholin-4-yl)-5-nitrophenyl]methanol is used as an intermediate in the synthesis of various organic compounds. Its unique structure and properties make it a preferred choice for creating a wide range of molecules with different applications across various industries.

Check Digit Verification of cas no

The CAS Registry Mumber 300665-25-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,0,6,6 and 5 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 300665-25:
(8*3)+(7*0)+(6*0)+(5*6)+(4*6)+(3*5)+(2*2)+(1*5)=102
102 % 10 = 2
So 300665-25-2 is a valid CAS Registry Number.

300665-25-2Relevant articles and documents

Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7, 26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27) ,16,21,23-decaene (SB1518), a potent Janus Kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma

William, Anthony D.,Lee, Angeline C.-H.,Blanchard, Stéphanie,Poulsen, Anders,Teo, Ee Ling,Nagaraj, Harish,Tan, Evelyn,Chen, Dizhong,Williams, Meredith,Sun, Eric T.,Goh, Kee Chuan,Ong, Wai Chung,Goh, Siok Kun,Hart, Stefan,Jayaraman, Ramesh,Pasha, Mohammed Khalid,Ethirajulu, Kantharaj,Wood, Jeanette M.,Dymock, Brian W.

, p. 4638 - 4658 (2011/09/14)

Discovery of the activating mutation V617F in Janus Kinase 2 (JAK2 V617F), a tyrosine kinase critically involved in receptor signaling, recently ignited interest in JAK2 inhibitor therapy as a treatment for myelofibrosis (MF). Herein, we describe the design and synthesis of a series of small molecule 4-aryl-2-aminopyrimidine macrocycles and their biological evaluation against the JAK family of kinase enzymes and FLT3. The most promising leads were assessed for their in vitro ADME properties culminating in the discovery of 21c, a potent JAK2 (IC50 = 23 and 19 nM for JAK2 WT and JAK2V617F, respectively) and FLT3 (IC50 = 22 nM) inhibitor with selectivity against JAK1 and JAK3 (IC50 = 1280 and 520 nM, respectively). Further profiling of 21c in preclinical species and mouse xenograft and allograft models is described. Compound 21c (SB1518) was selected as a development candidate and progressed into clinical trials where it is currently in phase 2 for MF and lymphoma.

Optimized and convergent synthesis of potent anti-malarial aminoquinoline compounds: Easy access to analogs

Le Fur, Nicolas,Larchanche, Paul-Emmanuel,Melnyk, Patricia

, p. 235 - 239 (2011/06/21)

Amodiaquine is one of the most active antimalarial 4-aminoquinoline. Previously we have described new analogs of amodiaquine and amopyroquine, in which the hydroxyl group was replaced by various amino groups and identified highly potent compounds. Here we

IMIDAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

-

Page/Page column 113-114, (2008/06/13)

Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula ( I ) represented by the following:The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 300665-25-2